Gabriele Tabaracci
Overview
Explore the profile of Gabriele Tabaracci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malatesta M, Tabaracci G, Pellicciari C
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684369
Ozone (O) is an unstable, highly oxidative gas that rapidly decomposes into oxygen. The therapeutic use of O dates back to the beginning of 20th century and is currently based...
2.
Inguscio C, Carton F, Cisterna B, Rizzi M, Boccafoschi F, Tabaracci G, et al.
Eur J Histochem
. 2024 Sep;
68(3).
PMID: 39252536
Medical treatment with low ozone concentrations proved to exert therapeutic effects in various diseases by inducing a cytoprotective antioxidant response through the nuclear factor erythroid derived-like 2 (Nrf2) transcription factor...
3.
Inguscio C, Cisterna B, Lacavalla M, Donati F, Angelini O, Tabaracci G, et al.
Eur J Histochem
. 2023 Oct;
67(4).
PMID: 37817677
Platelet-rich plasma (PRP) is gaining more and more attention in regenerative medicine as an innovative and efficient therapeutic approach. The regenerative properties of PRP rely on the numerous bioactive molecules...
4.
Inguscio C, Dalla Pozza E, Dando I, Boschi F, Tabaracci G, Angelini O, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37240245
The mild oxidative stress induced by low doses of gaseous ozone (O) activates the antioxidant cell response through the nuclear factor erythroid 2-related factor 2 (Nrf2), thus inducing beneficial effects...
5.
Lacavalla M, Inguscio C, Cisterna B, Bernardi P, Costanzo M, Galie M, et al.
Microsc Res Tech
. 2022 Sep;
85(12):3777-3792.
PMID: 36131631
Oxygen-ozone (O -O ) therapy is an adjuvant/complementary treatment based on the activation of antioxidant and cytoprotective pathways driven by the nuclear factor erythroid 2-related factor 2 (Nrf2). Many drugs,...
6.
Cisterna B, Costanzo M, Lacavalla M, Galie M, Angelini O, Tabaracci G, et al.
Int J Mol Sci
. 2021 Sep;
22(18).
PMID: 34576295
Oxygen-ozone (O-O) therapy is increasingly applied as a complementary/adjuvant treatment for several diseases; however, the biological mechanisms accounting for the efficacy of low O concentrations need further investigations to understand...
7.
Cisterna B, Costanzo M, Nodari A, Galie M, Zanzoni S, Bernardi P, et al.
Antioxidants (Basel)
. 2020 Oct;
9(10).
PMID: 33066365
In clinical practice, administration of low ozone (O) dosages is a complementary therapy for many diseases, due to the capability of O to elicit an antioxidant response through the Nuclear...
8.
Costanzo M, Romeo A, Cisterna B, Calderan L, Bernardi P, Covi V, et al.
Eur J Histochem
. 2020 Apr;
64(2).
PMID: 32241095
Exposure to low ozone concentrations is used in medicine as an adjuvant/complementary treatment for a variety of diseases. The therapeutic potential of low ozone concentrations relies on their capability to...
9.
Galie M, Covi V, Tabaracci G, Malatesta M
Int J Mol Sci
. 2019 Aug;
20(16).
PMID: 31426459
Ozone (O) is a natural, highly unstable atmospheric gas that rapidly decomposes to oxygen. Although not being a radical molecule, O is a very strong oxidant and therefore it is...
10.
Cisterna B, Boschi F, Croce A, Podda R, Zanzoni S, DeglInnocenti D, et al.
Microsc Microanal
. 2018 Oct;
24(5):564-573.
PMID: 30334518
The production of Amarone wine is governed by a disciplinary guideline to preserve its typical features; however, postharvest infections by the fungus Botrytis cinerea (B. cinerea) not only represent a...